TITAN, a phase 3 study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT) Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Merseburger, A. S.; Chowdhury, S.; Agarwal, N.; Bjartell, A.; Chung, B. H.; Pereira de Santana Gomes, A. J.; Given, R. W.; Soto, A. J.; Ozguroglu, M.; Uemura, H.; Ye, D. W.; Deprince, K.; Naini, V.; Li, J.; Cheng, S.; Yu, M. K.; Zhang, K.; Larsen, J. S.; McCarthy, S. A.; Chi, K. N.

publication date

  • January 1, 2019


published in


start page

  • 286

end page

  • 286


  • 42